PIL is emerging as one of the fastest growing pharmaceutical company in India, offering high quality products and services. The company has a CAGR of 25% for the last 5 years.
With 800 plus highly motivated and skilled employees and a world class manufacturing infrastructure with four WHO GMP approved plants, the company is poised to establish itself as one of the top Indian pharma company.
PIL has been focused in creating a risk-balanced and carefully diversified portfolio of products ranging from chronic diseasesegments like diabetes, neuropsychiatry, dermatologicals, pain management, anti infective, nutritionals, pet care products, affordable generics and strategic contract manufacturing to an attractive OTC/FMCG product range. This has been a key growth driver and has helped in establishing a good brand equity for PIL.
